Cytokinetics Inc
NASDAQ:CYTK
Cytokinetics Inc
NASDAQ:CYTK
Price:
67.49
USD
1.31%
Market Cap:
$8.3B
Balance Sheet
Balance Sheet Decomposition
Cytokinetics Inc
Cytokinetics Inc
Balance Sheet Decomposition is not available for
Cytokinetics Inc
Cytokinetics Inc
Balance Sheet
Cytokinetics Inc
Cytokinetics Inc
Currency: USD
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
11
|
16
|
10
|
13
|
14
|
39
|
117
|
42
|
26
|
18
|
19
|
15
|
20
|
20
|
65
|
67
|
125
|
42
|
36
|
83
|
113
|
66
|
615
|
95
|
|
| Cash Equivalents |
11
|
16
|
10
|
13
|
14
|
39
|
117
|
42
|
26
|
18
|
19
|
15
|
20
|
20
|
65
|
67
|
125
|
42
|
36
|
83
|
113
|
66
|
615
|
95
|
|
| Short-Term Investments |
41
|
10
|
24
|
93
|
63
|
70
|
3
|
15
|
71
|
54
|
30
|
59
|
58
|
63
|
46
|
89
|
144
|
157
|
189
|
381
|
359
|
717
|
502
|
981
|
|
| Total Receivables |
1
|
0
|
0
|
1
|
1
|
42
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
47
|
0
|
0
|
1
|
7
|
5
|
4
|
52
|
0
|
1
|
17
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
1
|
42
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
47
|
0
|
0
|
1
|
7
|
5
|
4
|
52
|
0
|
1
|
17
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
7
|
1
|
2
|
3
|
2
|
2
|
2
|
2
|
20
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
4
|
2
|
4
|
6
|
12
|
13
|
25
|
15
|
|
| Total Current Assets |
60
|
28
|
37
|
109
|
79
|
154
|
122
|
59
|
117
|
74
|
51
|
76
|
79
|
131
|
113
|
159
|
274
|
208
|
234
|
474
|
536
|
795
|
628
|
1 108
|
|
| PP&E Net |
8
|
10
|
9
|
7
|
6
|
9
|
8
|
5
|
4
|
2
|
1
|
1
|
1
|
2
|
2
|
4
|
4
|
3
|
13
|
23
|
146
|
163
|
148
|
141
|
|
| PP&E Gross |
8
|
10
|
9
|
7
|
6
|
9
|
8
|
5
|
4
|
2
|
1
|
1
|
1
|
2
|
2
|
4
|
4
|
3
|
13
|
23
|
146
|
163
|
148
|
141
|
|
| Accumulated Depreciation |
3
|
6
|
8
|
11
|
13
|
16
|
18
|
20
|
20
|
22
|
23
|
23
|
21
|
20
|
21
|
21
|
23
|
24
|
24
|
25
|
16
|
17
|
28
|
37
|
|
| Note Receivable |
0
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
10
|
4
|
8
|
5
|
0
|
0
|
20
|
17
|
0
|
1
|
0
|
0
|
3
|
0
|
0
|
8
|
17
|
0
|
43
|
37
|
152
|
47
|
41
|
145
|
|
| Other Long-Term Assets |
0
|
14
|
8
|
7
|
6
|
6
|
6
|
7
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
10
|
8
|
8
|
|
| Total Assets |
79
N/A
|
56
-29%
|
63
+12%
|
128
+104%
|
92
-29%
|
170
+85%
|
155
-8%
|
88
-44%
|
123
+40%
|
78
-36%
|
53
-32%
|
78
+47%
|
83
+7%
|
133
+60%
|
115
-13%
|
170
+48%
|
295
+73%
|
211
-28%
|
290
+37%
|
534
+84%
|
841
+58%
|
1 015
+21%
|
824
-19%
|
1 402
+70%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
5
|
2
|
2
|
2
|
2
|
3
|
2
|
1
|
2
|
1
|
1
|
2
|
4
|
1
|
2
|
4
|
5
|
4
|
8
|
8
|
21
|
26
|
86
|
20
|
|
| Accrued Liabilities |
1
|
2
|
3
|
4
|
4
|
8
|
9
|
7
|
6
|
5
|
3
|
5
|
8
|
5
|
8
|
18
|
17
|
16
|
17
|
22
|
49
|
57
|
61
|
74
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
2
|
2
|
2
|
3
|
4
|
4
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
3
|
0
|
0
|
1
|
1
|
11
|
12
|
|
| Other Current Liabilities |
3
|
3
|
3
|
3
|
2
|
12
|
12
|
12
|
1
|
0
|
0
|
0
|
15
|
17
|
21
|
9
|
10
|
0
|
1
|
1
|
1
|
1
|
10
|
73
|
|
| Total Current Liabilities |
10
|
9
|
10
|
11
|
11
|
26
|
26
|
23
|
20
|
7
|
5
|
7
|
27
|
24
|
32
|
33
|
32
|
22
|
26
|
31
|
72
|
85
|
103
|
180
|
|
| Long-Term Debt |
4
|
7
|
8
|
8
|
7
|
7
|
5
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
15
|
27
|
32
|
40
|
129
|
136
|
144
|
611
|
608
|
646
|
|
| Other Liabilities |
10
|
7
|
4
|
1
|
0
|
30
|
24
|
12
|
0
|
0
|
0
|
0
|
2
|
17
|
0
|
15
|
121
|
123
|
146
|
254
|
382
|
427
|
500
|
712
|
|
| Total Liabilities |
23
N/A
|
24
+2%
|
22
-8%
|
21
-6%
|
18
-13%
|
63
+253%
|
56
-12%
|
38
-32%
|
21
-44%
|
8
-65%
|
5
-39%
|
8
+63%
|
29
+283%
|
41
+43%
|
47
+14%
|
76
+63%
|
185
+144%
|
185
+0%
|
301
+62%
|
420
+40%
|
598
+42%
|
1 123
+88%
|
1 211
+8%
|
1 537
+27%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
93
|
93
|
133
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
38
|
61
|
94
|
131
|
174
|
231
|
280
|
336
|
311
|
361
|
409
|
449
|
483
|
497
|
535
|
518
|
646
|
743
|
865
|
992
|
1 208
|
1 586
|
2 112
|
2 702
|
|
| Additional Paid In Capital |
1
|
1
|
6
|
243
|
250
|
338
|
380
|
386
|
413
|
431
|
457
|
519
|
537
|
589
|
603
|
613
|
756
|
769
|
853
|
1 106
|
1 452
|
1 482
|
1 726
|
2 564
|
|
| Other Equity |
0
|
0
|
4
|
4
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
4
|
0
|
2
|
|
| Total Equity |
56
N/A
|
33
-42%
|
41
+26%
|
108
+162%
|
74
-32%
|
106
+44%
|
100
-6%
|
50
-50%
|
101
+104%
|
71
-30%
|
48
-32%
|
70
+45%
|
54
-22%
|
92
+69%
|
69
-26%
|
94
+38%
|
110
+16%
|
26
-76%
|
11
N/A
|
113
N/A
|
244
+115%
|
108
N/A
|
386
-258%
|
135
+65%
|
|
| Total Liabilities & Equity |
79
N/A
|
56
-29%
|
63
+12%
|
128
+104%
|
92
-29%
|
170
+85%
|
155
-8%
|
88
-44%
|
123
+40%
|
78
-36%
|
53
-32%
|
78
+47%
|
83
+7%
|
133
+60%
|
115
-13%
|
170
+48%
|
295
+73%
|
211
-28%
|
290
+37%
|
534
+84%
|
841
+58%
|
1 015
+21%
|
824
-19%
|
1 402
+70%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
6
|
6
|
4
|
5
|
5
|
7
|
8
|
8
|
10
|
11
|
13
|
24
|
31
|
39
|
40
|
41
|
54
|
55
|
59
|
71
|
85
|
95
|
102
|
118
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
